State of Biopharma Tech Q1’22 Report
After a record-breaking 2021, global biopharma tech investment cooled off in Q1’22.
Pharma & Biotech
Here are the 9 most impressive biopharma founding teams funded in the past 2 years — and what they signal about the future of the industry
Of the 2,700+ recently funded biopharma companies, we identified 9 of the top teams using our Management Mosaic algorithm. From clinical trials tech to anti-aging drugs, proven founders and teams are innovating in new sectors.
Drug price transparency and cost mitigation software Waltz Health raises $35.4M in round led by GV. Waltz Health competitors are Blink Health, GoodRx, Hoy Health, Rightway, and RxRevu.
The funding will help Waltz Health hire new employees and invest in product development. Here are the top-line bullets you need to know.
Hospital at home: 140+ companies bringing care directly to patient homes
As care delivery shifts out of the hospital and into the home, these startups are driving home health innovation.
DNAnexus hits $600M valuation for its cloud-based biomedical data analysis software. DNAnexus competitors include Seven Bridges, BC Platforms, and Lifebit.
This news comes on the heels of its Series I round. The funding will help DNAnexus support product development and international growth. Here are the top-line bullets you need to know.
MVP Technology Framework: Clinical Trials for Pharma and CRO Leaders
This report uses the CB Insights MVP Technology Framework to rank tech market planning decisions and give an adoption playbook for the clinical trials domain.
Unbundling Illumina: How the gene sequencing giant is being disrupted
From precision medicine to genetic screening, here’s how Illumina is being unbundled.
Analyzing Amazon’s healthcare growth strategy: How the tech giant is shaping the future of the $5T industry
Investment Thesis Map
We mined Amazon's acquisitions, investments, and partnerships to discern the company's strategic priorities in healthcare.
Analyzing Johnson & Johnson’s Growth Strategy: How The Pharma Giant Is Going Digital
Investment Thesis Map
We mined Johnson & Johnson’s acquisitions, investments, and partnerships to discern the company's strategic priorities.
LabCorp Acquires Cancer Genomics And Liquid Biopsy Company Personal Genome Diagnostics (PGDx) For $450M — A 20.5x Price/Revenue Valuation Multiple
With the acquisition, LabCorp plans to enhance its liquid biopsy and NGS-based genomic profiling capabilities. Here are the top-line bullets you need to know.
Tech Market Map Report — Clinical Trials In Healthcare
This report looks at the clinical trials tech companies serving pharmaceutical companies and CROs.
Our Top 2021 Healthcare Reports
The pandemic has forced us to reimagine all aspects of healthcare delivery. Discover what’s changed across telehealth, digital therapeutics, medical devices, and more.
The Big Tech In Pharma Report: How Amazon, Microsoft, Apple, And Google Are Capitalizing On The Digital Transformation
The pandemic has exposed challenges in the pharmaceutical industry, from drug discovery to clinical trials to supply chain. Here’s how Apple, Microsoft, Google, and Amazon are addressing them and working to establish permanent places for themselves in the space through product launches, partnerships, M&A deals, and more.
Electronic Lab Notebook Firm Benchling Raises At A $6B Valuation — A Trailing Price/Revenue Valuation Multiple Of 122x
The Series F round brings Benchling's total funding to $412M. Here are the top-line bullets you need to know.
Digital Clinical Research Platform For Drug Development Owkin Raises $180M At A Unicorn Valuation
Owkin has raised $254.1M in funding to date. Here are the top-line bullets you need to know.
Betting On Magic: Funding For Psychedelics Startups Reaches A Record High
Funding to psychedelics startups is on the rise. We discuss the sector’s market drivers, emerging themes, and key implications.
Healthcare Research: Startups, Trends, Tech Solutions & More
Here’s a sample of our digital health and healthcare research on the sector’s investment and funding trends, business models, tech solutions, and more.
Clinical Trial Management Company Moves Into Drug Development After Raising $156M In Series C Funding
The Series C funding helps TrialSpark reach a $1B valuation. Here are the top-line bullets you need to know.
Global Genomic Data Platform For Drug Discovery Lifebit Raises $60M In Series B Led By Tiger Global
Lifebit's total funding now stands at $70.5M. Here are the top-line bullets you need to know.
Pharma, Payers, And Providers Are Pushing Into Digital Therapeutics. Here Are The Partnerships Shaping The Sector’s Future.
Using CB Insights’ Business Relationships data, we map out and analyze the growing number of business relationships between digital therapeutics startups and payers, providers, and pharmaceutical companies.
What Is CRISPR?
CRISPR. What is it? And why is the scientific community so fascinated by the potential applications of this gene-editing technology? Starting with its definition, we explain how this technology harnesses an ancient bacteria-based defense system — and how it will impact the world around us today.
Unbundling Contract Research Organizations (CROs): The Tech Companies Targeting New Opportunities In Pharma Services
From drug discovery to predictive analytics, here’s how emerging tech companies are disrupting the CRO model.
The Big Tech In Pharma Report: From Digital Pharmacies, AI For Drug Discovery, & Apps For Medical Records, How Amazon, Microsoft, Apple, and Google Will Reimagine The Industry Value Chain
Big tech is coming for pharma. We analyze Amazon, Microsoft, Apple, and Google’s strategies and priorities across the pharmaceutical value chain.
Tech Market Map Report — Pharmaceutical Supply Chain In Healthcare
This report looks at the supply chain companies serving pharmaceutical companies.
Digital Therapeutics Outlook: The Tech Transforming The Way We Treat And Manage Disease
Digital therapeutics are a growing focus within the digital health ecosystem, as funding, clinical validation, and product reimbursement gain momentum. We analyze the accelerating adoption of digital therapeutics and how they can improve patient outcomes.
Softbank-Backed Exscientia Raises $225M To Enhance Its Autonomous Drug Design Platform
Exscientia plans to advance its pipeline of AI-designed drugs into clinical testing. Here are the top line bullets you need to know.